Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zahedi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zahedi, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 25, Issue of June 21, 1996 pp. 14897-14902
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Characterization of the Binding of Serum Amyloid P to Type IV Collagen

(Received for publication, August 14, 1995, and in revised form, March 18, 1996)

Kamyar Zahedi

From the Division of Nephrology, Children's Hospital Research Foundation and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229-3039

Serum amyloid P (SAP), a member of the evolutionarily conserved pentraxin family, is a normal component of a number of basement membranes, including glomerular and alveolar. In vitro SAP binds to a variety of proteins including fibronectin, proteoglycans, and the collagen-like region of the complement component C1q. In these studies, binding of SAP to type IV collagen, a major component of basement membrane, was examined. Purified SAP binds to human and mouse type IV collagen but not type I, II, or III collagens. Binding of SAP to type IV collagen is dependent on the presence of Ca2+. This binding is saturable with a Kd approx  1.2 × 10-7 M based on solid phase binding and 4 × 10-8 M based on the IC50 value from fluid phase binding data. Binding of SAP to type IV collagen was inhibited by both SAP and C-reactive protein (CRP). However, a 5-fold molar excess of CRP as compared with SAP was required to inhibit the SAP binding by 50%. Binding of SAP to type IV collagen was inhibited by both collagen IV and C1q but not by phosphatidylethanolamine or bovine serum albumin. The inhibition data indicate that SAP may bind to the triple helical region of type IV collagen via a site distinct from its galactan binding site. The most likely site of SAP involved in its interaction with type IV collagen may be the region spanning amino acid residues 108-120, which shows a great deal of sequence homology (60% strict identity) with the CRP region implicated in its binding to the collagen-like region of the C1q molecule.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Scarchilli, A. Camaioni, B. Bottazzi, V. Negri, A. Doni, L. Deban, A. Bastone, G. Salvatori, A. Mantovani, G. Siracusa, et al.
PTX3 Interacts with Inter-{alpha}-trypsin Inhibitor: IMPLICATIONS FOR HYALURONAN ORGANIZATION AND CUMULUS OOPHORUS EXPANSION
J. Biol. Chem., October 12, 2007; 282(41): 30161 - 30170.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. De Celle, F. Vanrobaeys, P. Lijnen, W. M. Blankesteijn, S. Heeneman, J. Van Beeumen, B. Devreese, J. F. M Smits, and B. J. A Janssen
Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion
Exp Physiol, July 1, 2005; 90(4): 593 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Pilling, C. D. Buckley, M. Salmon, and R. H. Gomer
Inhibition of Fibrocyte Differentiation by Serum Amyloid P
J. Immunol., November 15, 2003; 171(10): 5537 - 5546.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kimura, S. Tani, Y.-i. Matsumoto, and T. Takeda
Serum Amyloid P Component Is the Shiga Toxin 2-neutralizing Factor in Human Blood
J. Biol. Chem., November 2, 2001; 276(45): 41576 - 41579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Cherry, N. Menhart, and L. W.-M. Fung
Interactions of the alpha -Spectrin N-terminal Region with beta -Spectrin. IMPLICATIONS FOR THE SPECTRIN TETRAMERIZATION REACTION
J. Biol. Chem., January 22, 1999; 274(4): 2077 - 2084.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Bottazzi, V. Vouret-Craviari, A. Bastone, L. De Gioia, C. Matteucci, G. Peri, F. Spreafico, M. Pausa, C. D'Ettorre, E. Gianazza, et al.
Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3. SIMILARITIES AND DIFFERENCES WITH THE SHORT PENTRAXINS C-REACTIVE PROTEIN AND SERUM AMYLOID P COMPONENT
J. Biol. Chem., December 26, 1997; 272(52): 32817 - 32823.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Zahedi and K. Zahedi
Characterization of the Binding of Serum Amyloid P to Laminin
J. Biol. Chem., January 24, 1997; 272(4): 2143 - 2148.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement